Health and Human Services Secretary Alex Azar today released a plan outlining two pathways the administration intends to explore to safely import certain drugs originally intended for foreign markets. The plan calls for HHS and the Food and Drug Administration to issue a proposed rule authorizing demonstration projects to import drugs from Canada safely at lower cost. States, wholesalers and pharmacists could submit demonstration proposals for review. It also calls for FDA to issue guidance for manufacturers seeking to import FDA-approved drug products that they sell in foreign countries to potentially offer them at a lower price than their current distribution contracts require.

Related News Articles

Headline
The Senate Finance Committee today voted 19-9 to pass the Prescription Drug Pricing Reduction Act, legislation to reduce drug costs.
Headline
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the…
Headline
The House Energy and Commerce Committee today approved legislation to address surprise medical bills and Medicaid disproportionate share hospital cuts.
Headline
The Trump administration today withdrew a proposed rule that would eliminate the rebate safe harbor for pharmacy benefit managers under the federal anti-…
Headline
A federal judge yesterday struck down a Centers for Medicare…
Headline
Drug makers this week increased list prices for at least 104 different drugs, dosages or package sizes, with the average price increase 13.1%, according to an…